We also show that de novo SOX11 expression is associated with aggressive lymphoid malignancies like MCL, some ALL subtypes and a fraction of BL cases, being this effect mediated by a switch between inactivating and activating histone modifications. This evidence concerns the gene SOX11 and acute lymphoblastic leukemia.